Skip to main content
. 2019 Mar 14;10:459. doi: 10.3389/fimmu.2019.00459

Figure 3.

Figure 3

IL-2/JES6-1 immunocomplex administration promotes intestinal ILC2 expansion and IL-5 expression. WT mice were treated with 3% DSS for 6 days and received normal water thereafter. IL-2/JES6-1 immunocomplexes were delivered every 2 days. IL-5 mRNA expression in total colon tissue was analyzed by quantitative real-time PCR (A). LPL from each mouse were restimulated by PMA/ionomycin and ILC2 cells were analyzed by flow cytometry. Represent dot plots are shown in (B) and the frequency and total cell numbers are shown in (C) after pre-gating on live, lin- cells. IL-5+ILC2 were analyzed by flow cytometry (D). Data are representative of two independent experiments with 4–6 mice/group. All data are presented as mean ± SEM; *P < 0.05, ***P < 0.001, one-way ANOVA with Tukey's multiple comparison test.